(3 references)-
- 抗原 See all C1q 抗体
- C1q (Complement Fragment C1q (C1q))
-
适用
- 人
-
宿主
-
绵羊
-
克隆类型
- 多克隆
-
标记
- This C1q antibody is conjugated to FITC
-
应用范围
- Immunohistochemistry (Frozen Sections) (IHC (fro))
- 产品特性
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
- 免疫原
- Human C1q, purified from plasma
- 亚型
- IgG
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 10 mg/mL
-
-
: "Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable ..." in: Molecular immunology, Vol. 45, Issue 9, pp. 2570-80, (2008) (PubMed).
: "Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents." in: Blood, Vol. 103, Issue 7, pp. 2738-43, (2004) (PubMed).
: "Inhibition of C1q-beta-amyloid binding protects hippocampal cells against complement mediated toxicity." in: Journal of neuroimmunology, Vol. 137, Issue 1-2, pp. 12-8, (2003) (PubMed).
-
: "Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable ..." in: Molecular immunology, Vol. 45, Issue 9, pp. 2570-80, (2008) (PubMed).
-
-
You are here:
